🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

POHCA Resuscitation: Evaluation of IM Epinephrine

RecruitingPhase 2, Phase 3Ages 1 Day - 17 YearsAllLondon Health Sciences Centre Research Institute …
NCT05166343 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a pragmatic, two-arm, open-label, prospective stepped-wedge cluster quasi randomized control trial (SW-CRCT) looking to evaluate early intramuscular (IM) epinephrine in the management of pediatric out-of-hospital cardiac arrest (POHCA).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Children aged 1 day to and including 17 years experiencing an out-of-hospital cardiac arrest (OHCA) * Must be receiving at least 1 minute of CPR by trained first responders (police, fire, or paramedic services) Exclusion Criteria: \- Children who experience OHCA due to an obvious traumatic event.
💊

What it tests

  • Epinephrine Injection
📍

Where

1 site
Children's Hospital - London Health Sciences Centre
London, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy